Generics in Brazil - Market Summary, Competitive Analysis and Forecast to 2025
Generics in Brazil - Market Summary, Competitive Analysis and Forecast to 2025
Abstract
Summary
Generics in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Brazilian generics market had total revenues of $5.3bn in 2020, representing a compound annual growth rate (CAGR) of 9.9% between 2016 and 2020.
- Market consumption volume increased with a CAGR of 3.2% between 2016 and 2020, to reach a total of 36.1 % in 2020.
- Growth in the Brazilian market has been driven by a bourgeoning middle class and an aging population, who are more likely to have chronic diseases.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Brazil
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Brazil
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Brazil generics market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the Brazil generics market by value in 2020?
- What will be the size of the Brazil generics market in 2025?
- What factors are affecting the strength of competition in the Brazil generics market?
- How has the market performed over the last five years?
- Who are the top competitiors in Brazil's generics market?
Content
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the COVID-19 pandemic impacted leading players?
8 Company Profiles
8.1. Sanofi SA
8.2. EMS SA
8.3. Ache Laboratorios Farmaceuticos SA
8.4. Eurofarma Laboratorios SA
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Brazil generics market value: $ million, 2016-20
Table 2: Brazil generics market volume: %, 2016-20
Table 3: Brazil generics market geography segmentation: $ million, 2020
Table 4: Brazil generics market value forecast: $ million, 2020-25
Table 5: Brazil generics market volume forecast: %, 2020-25
Table 6: Sanofi SA: key facts
Table 7: Sanofi SA: Annual Financial Ratios
Table 8: Sanofi SA: Key Employees
Table 9: Sanofi SA: Key Employees Continued
Table 10: EMS SA: key facts
Table 11: EMS SA: Key Employees
Table 12: Ache Laboratorios Farmaceuticos SA: key facts
Table 13: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 14: Eurofarma Laboratorios SA: key facts
Table 15: Eurofarma Laboratorios SA: Key Employees
Table 16: Brazil size of population (million), 2016-20
Table 17: Brazil gdp (constant 2005 prices, $ billion), 2016-20
Table 18: Brazil gdp (current prices, $ billion), 2016-20
Table 19: Brazil inflation, 2016-20
Table 20: Brazil consumer price index (absolute), 2016-20
Table 21: Brazil exchange rate, 2016-20
List of Figures
Figure 1: Brazil generics market value: $ million, 2016-20
Figure 2: Brazil generics market volume: %, 2016-20
Figure 3: Brazil generics market geography segmentation: % share, by value, 2020
Figure 4: Brazil generics market value forecast: $ million, 2020-25
Figure 5: Brazil generics market volume forecast: %, 2020-25
Figure 6: Forces driving competition in the generics market in Brazil, 2020
Figure 7: Drivers of buyer power in the generics market in Brazil, 2020
Figure 8: Drivers of supplier power in the generics market in Brazil, 2020
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2020
Figure 10: Factors influencing the threat of substitutes in the generics market in Brazil, 2020
Figure 11: Drivers of degree of rivalry in the generics market in Brazil, 2020
Summary
Generics in Brazil industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value and volume 2016-20, and forecast to 2025). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Key Highlights
- For the purposes of this profile, a generic drug is defined as a copy of an ethical (prescription) drug formerly protected by patents that have now expired. Both unbranded generics and all branded generics are included. However, off-patent drugs that continue to be offered by the original manufacturer under the original name, and which form part of the 'generic-eligible' market, are not included.
- The Brazilian generics market had total revenues of $5.3bn in 2020, representing a compound annual growth rate (CAGR) of 9.9% between 2016 and 2020.
- Market consumption volume increased with a CAGR of 3.2% between 2016 and 2020, to reach a total of 36.1 % in 2020.
- Growth in the Brazilian market has been driven by a bourgeoning middle class and an aging population, who are more likely to have chronic diseases.
Scope
- Save time carrying out entry-level research by identifying the size, growth, and leading players in the generics market in Brazil
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the generics market in Brazil
- Leading company profiles reveal details of key generics market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the Brazil generics market with five year forecasts by both value and volume
Reasons to Buy
- What was the size of the Brazil generics market by value in 2020?
- What will be the size of the Brazil generics market in 2025?
- What factors are affecting the strength of competition in the Brazil generics market?
- How has the market performed over the last five years?
- Who are the top competitiors in Brazil's generics market?
Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Market volume
1.4. Market volume forecast
1.5. Geography segmentation
1.6. Market rivalry
1.7. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
3.2. Market volume
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
5.2. Market volume forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Who are the leading players?
7.2. What are the strengths/weaknesses of the leading players?
7.3. Has there been any significant recent M&A activity?
7.4. How has the COVID-19 pandemic impacted leading players?
8 Company Profiles
8.1. Sanofi SA
8.2. EMS SA
8.3. Ache Laboratorios Farmaceuticos SA
8.4. Eurofarma Laboratorios SA
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine
List of Tables
Table 1: Brazil generics market value: $ million, 2016-20
Table 2: Brazil generics market volume: %, 2016-20
Table 3: Brazil generics market geography segmentation: $ million, 2020
Table 4: Brazil generics market value forecast: $ million, 2020-25
Table 5: Brazil generics market volume forecast: %, 2020-25
Table 6: Sanofi SA: key facts
Table 7: Sanofi SA: Annual Financial Ratios
Table 8: Sanofi SA: Key Employees
Table 9: Sanofi SA: Key Employees Continued
Table 10: EMS SA: key facts
Table 11: EMS SA: Key Employees
Table 12: Ache Laboratorios Farmaceuticos SA: key facts
Table 13: Ache Laboratorios Farmaceuticos SA: Key Employees
Table 14: Eurofarma Laboratorios SA: key facts
Table 15: Eurofarma Laboratorios SA: Key Employees
Table 16: Brazil size of population (million), 2016-20
Table 17: Brazil gdp (constant 2005 prices, $ billion), 2016-20
Table 18: Brazil gdp (current prices, $ billion), 2016-20
Table 19: Brazil inflation, 2016-20
Table 20: Brazil consumer price index (absolute), 2016-20
Table 21: Brazil exchange rate, 2016-20
List of Figures
Figure 1: Brazil generics market value: $ million, 2016-20
Figure 2: Brazil generics market volume: %, 2016-20
Figure 3: Brazil generics market geography segmentation: % share, by value, 2020
Figure 4: Brazil generics market value forecast: $ million, 2020-25
Figure 5: Brazil generics market volume forecast: %, 2020-25
Figure 6: Forces driving competition in the generics market in Brazil, 2020
Figure 7: Drivers of buyer power in the generics market in Brazil, 2020
Figure 8: Drivers of supplier power in the generics market in Brazil, 2020
Figure 9: Factors influencing the likelihood of new entrants in the generics market in Brazil, 2020
Figure 10: Factors influencing the threat of substitutes in the generics market in Brazil, 2020
Figure 11: Drivers of degree of rivalry in the generics market in Brazil, 2020
Related Report
